Harrow, Inc. (HROW)
49.10
+1.98
(+4.20%)
USD |
NASDAQ |
Feb 13, 12:26
Harrow Free Cash Flow : -20.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Assertio Holdings, Inc. | 13.33M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 16.59M |
| Cash from Investing (Quarterly) | -0.225M |
| Cash from Financing (Quarterly) | 4.964M |
| Free Cash Flow Per Share (Quarterly) | 0.4209 |
| Free Cash Flow to Equity (Quarterly) | -4.258M |
| Free Cash Flow to Firm (Quarterly) | 22.40M |
| Free Cash Flow Yield | -1.12% |